Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (231-240 of 277) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 29, 2020
Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization StudyGeffen Kleinstern, Nicola J Camp, Sonja I Berndt, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingJens G Lohr, Petar Stojanov, Michael S Lawrence, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Ebiomedicine|April 22, 2023
The association between genetically elevated polyunsaturated fatty acids and risk of cancerPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
American Journal of Epidemiology|January 6, 2010
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph ConsortiumChristine F Skibola, Paige M Bracci, Alexandra Nieters, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.
Pageof 28

Showing results (231-240 of 277) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 29, 2020
Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization StudyGeffen Kleinstern, Nicola J Camp, Sonja I Berndt, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingJens G Lohr, Petar Stojanov, Michael S Lawrence, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Ebiomedicine|April 22, 2023
The association between genetically elevated polyunsaturated fatty acids and risk of cancerPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
American Journal of Epidemiology|January 6, 2010
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph ConsortiumChristine F Skibola, Paige M Bracci, Alexandra Nieters, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.
Pageof 28